You are here: Industry Insights > vaccine

News List

Prior SARS-CoV-2 Infection Ups Protection for Vaccinated Drugs
November 16, 2021
For individuals vaccinated with mRNA COVID-19 vaccines, prior severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is associated with a lower risk for breakthrough infection...
AstraZeneca to transition to ‘modest profitability’ on future COVID-19 vaccine orders CPhIonline
November 16, 2021
AstraZeneca will start to receive a modest profit from its COVID-19 vaccine as part of a post-pandemic commercial approach, the Anglo-Swedish drugmaker announced at a press conference on Friday.
Johnson & Johnson COVID-19 vaccine named one of Time's Best Inventions of 2021 WorldPharmaNews
November 15, 2021
The editors of Time announced that the Johnson & Johnson COVID-19 vaccine has been selected as one of Time's Best Inventions of 2021.
Estimated Coverage With Measles Vaccine Down in 2020 Drugs
November 15, 2021
The estimated measles-containing vaccine first dose (MCV1) coverage increased globally to a peak in 2019, then decreased in 2020, according to research published in the Nov. 12 issue...
Bharat Biotech MD says Ideal time for COVID booster shot is six months after second dose ExpressPharma
November 12, 2021
The ideal time for a booster dose for COVID-19 vaccine is six months after the second dose, Krishna Ella, Chairman and Managing Director, Bharat Biotech, said yesterday...
Nearly 900,000 U.S. Children Under 12 Have Gotten Their First COVID-19 Shot Drugs
November 11, 2021
About 900,000 U.S. children aged 5 to 11 years received their initial dose of the Pfizer COVID-19 vaccine during the first week of eligibility for that age group, the Biden administration said Wednesday.
New protein-based COVID vaccine doesn’t need cold storage: Study ExpressPharma
November 09, 2021
Scientists have developed a new protein-based vaccine candidate for COVID-19? that they say is much easier to produce and does not need refrigeration.
Ocugen seeks FDA EUA for Covid-19 vaccine use in children Pharmaceutical-Technology
November 08, 2021
Ocugen has sought Emergency Use Authorization (EUA) from the US Food and Drug Administration (FDA) for its Covid-19? vaccine candidate, BBV152, for use in children in the age group of two to 18 years.
Pfizer raises COVID vaccine sales forecast to $36 billion for 2021 ExpressPharma
November 08, 2021
Pfizer recently raised the full-year sales forecast for its COVID-19 vaccine by 7.5 per cent to $36 billion, as it signs deals with countries for booster doses and receives clearances for using its shots in children.
US authorises more batches of J&J COVID-19 vaccine made at Emergent ExpressPharma
November 08, 2021
The US Food and Drug Administration (FDA) said it had authorised the use of two more batches of Johnson & Johnson’s one-dose COVID-19 vaccine manufactured at the problem-plagued Baltimore...